Results 71 to 80 of about 19,281 (268)

Solutions of nonlinear evolution inclusions

Journal of Mathematical Analysis and Applications, 2006
The authors consider the nonlinear evolution inclusion \[ \frac{du} {dt}+B\bigl( t,u(t)\bigr)\ni f(t),\quad t\in[0,T]\quad u(0)=u_0,\tag{1} \] in a real reflexive Banach space \(V\) with dual \(V^*\), in which \(B:[0,T]\times V \to V^*\) is measurable and nonempty closed convex set-valued and \(f\in L^q(V^*)\).
Ke, Su, Zhen, He
openaire   +1 more source

Ironic Medications: A Narrative‐Based Psycho‐Educational Intervention to Explore Patient–Provider Communication in Adolescents With Haematological Cancer

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Adolescents with haematological malignancies face significant emotional and relational challenges, often accompanied by difficulties in communicating their needs within the healthcare context. To address these issues, a narrative‐based psycho‐educational intervention based on the creation and prescription of Ironic Medications was ...
Marta Stoppa, Elena Pagani Bagliacca, Selena Russo, Giulia Rampoldi, Maria Grazia Strepparava, Adriana Cristina Balduzzi, Andrea Biondi, Marco Spinelli   +7 more
wiley   +1 more source

Effect of Acid Slag Treatment on the Inclusions in GCr15 Bearing Steel

High Temperature Materials and Processes, 2019
By laboratory slag/steel reaction equilibrim experiments, the viriation of oxygen content, inclusion compositions and inclusion sizes were studied. The effect of acid slag treatment on the transition mechanisms of D-type inclusions and the precipitation ...
Liu Yang, Li Jing, Ge Jinpeng, Zheng Dingli   +3 more
doaj   +1 more source

Incidence and Severity of Carboplatin‐Associated Hearing Loss in Children With Cancer Assessed by the SIOP Boston 2012 Ototoxicity Criteria

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Platinum‐based chemotherapy is known to cause severe and debilitating hearing loss, but unlike cisplatin, the true incidence of carboplatin‐induced hearing loss remains unclear. We evaluated functional hearing outcomes in children receiving carboplatin to determine the incidence and severity of ototoxicity. Procedure We identified a
Aniket Chawla, Sean Carter, Andrew Wood, Sandra Staffieri, Andrew Dodgshun, David D. Eisenstat, Michael Sullivan   +6 more
wiley   +1 more source

Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with recurrent diffuse midline gliomas (DMGs) have limited therapeutic options at recurrence. Re‐irradiation (RT2) may be used at progression, but with uncertainty about the benefit. Methods We conducted a multi‐institutional retrospective study of children aged < 18 with DMG treated at three centers (Toronto, Canada ...
Ajay Thomas Alex, Sean P. Hassan, Helen Benghiat, Liam Herbert, Jennifer Adamski, Shivani Bailey, Claire Esler, Louise Brookes, Molly Bamber, Grace Koudou, Karen Waite, Julie Bennett, Anirban Das, Derek S. Tsang   +13 more
wiley   +1 more source

Semilinear evolution inclusions with nonlocal conditions

Applied Mathematics Letters, 2009
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire   +1 more source

On nonlinear, nonconvex evolution inclusions

Kodai Mathematical Journal, 1995
The paper contrasts the sets \(S(x_0)\) and \(S_e(x_0)\) of integral solutions of Benilan to the differential systems \(- x'(t)\in Ax(t)+ F(t, x(t))\), \(x(0)= x_0\) and \(-x'(t)\in Ax(t)+ \text{ext } F(t, x(t))\), \(x(0)= x_0\) respectively, where ext stands for the set of extreme points. The main results state that, for every \(x_0\in \overline D\), \
Hu, Shou Chuan, Papageorgiou, Nikolaos S.   +1 more
openaire   +2 more sources

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko, Holger N. Lode, Alberto Garaventa, Carla Manzitti, Roberto Luksch, Dominique Valteau‐Couanet, Marion Gambart, John Anderson, Juliet Gray, Adela Canete, Lucas Moreno, Aleksandra Wieczorek, Cormac Owens, Shifra Ash, Isaac Yaniv, Genevieve Laureys, Hans Loibner, Katarzyna Śladowska, Ruth Ladenstein, Paweł Kawalec   +19 more
wiley   +1 more source

Evolution of Cellular Inclusions in Bietti’s Crystalline Dystrophy

Ophthalmology and Eye Diseases, 2010
Bietti’s crystalline dystrophy (BCD) consists of small, yellow-white, glistening intraretinal crystals in the posterior pole, tapetoretinal degeneration with atrophy of the retinal pigment epithelium (RPE) and “sclerosis” of the choroid; in addition ...
Emiko Furusato, J. Douglas Cameron, Chi-Chao Chan   +2 more
doaj  

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol, Arlene Naranjo, Lulu Chen, Rajen Mody, Steven G. DuBois, Rochelle Bagatell, Navin Pinto   +6 more
wiley   +1 more source